Enoxaparin Sodium Powder
NDC Package 62255-1325-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Enoxaparin Sodium powders is enoxaparin is used to prevent and treat harmful blood clots. This formulation utilizes a powder delivery system. Marketed by Sanofi-aventis Singapore Pte. Ltd., this product is identified by NDC 62255-1325.

Identification & Billing

NDC Package Code
62255-1325-1
Package Description
36.9 kg in 1 DRUM
Product Code
62255-1325
11-Digit Billing Format
62255132501

Clinical Specifications

Proprietary Name
Enoxaparin Sodium
Non-Proprietary Name
Enoxaparin Sodium
Substance Name
Enoxaparin Sodium
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s)
ENOXAPARIN SODIUM 1 kg/kg
Usage Information
Enoxaparin is used to prevent and treat harmful blood clots. This helps to reduce the risk of a stroke or heart attack. This medication helps keep your blood flowing smoothly by lowering the activity of clotting proteins in the blood. Enoxaparin is an anticoagulant, also known as a "blood thinner." It is a type of heparin. Conditions which increase your risk of developing blood clots include certain types of surgeries (such as knee/hip replacement, abdominal), long periods of being immobile, certain types of heart attack, and a specific type of chest pain called unstable angina. For some medical conditions, enoxaparin may be used in combination with other "blood thinners."

Regulatory & Marketing

Labeler Name
Sanofi-aventis Singapore Pte. Ltd.
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
10-03-2011
Listing Expiration
12-31-2027
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62255-1325-1 identifies a specific commercial package of 36.9 kg in 1 drum of Enoxaparin Sodium (UNFINISHED drug), a bulk ingredient labeled by Sanofi-aventis Singapore Pte. Ltd.. This powder is formulated for use and contains enoxaparin sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sanofi-aventis Singapore Pte. Ltd. on October 03, 2011. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Enoxaparin is used to prevent and treat harmful blood clots. This helps to reduce the risk of a stroke or heart attack. This medication helps keep your blood flowing smoothly by lowering the activity of clotting proteins in the blood. Enoxaparin is an anticoagulant, also known as a "blood thinner." It is a type of heparin. Conditions which increase your risk of developing blood clots include certain types of surgeries (such as knee/hip replacement, abdominal), long periods of being immobile, certain types of heart attack, and a specific type of chest pain called unstable angina. For some medical conditions, enoxaparin may be used in combination with other "blood thinners."

How is this Sanofi-aventis Singapore Pte. Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62255132501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
62255-1325-1
11-Digit CMS (5-4-2)
62255-1325-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.